Koronis: Developing a new treatment for HIV
03. Jun, 2009 
0 Comments
I recently had the opportunity to conduct a brief interview with Jeff Parkins, Vice President of Clinical Development and Regulatory at Koronis on his company and the future of the biotechnology industry:
Can you tell me a little bit about Koronis and its mission?
Koronis Pharmaceuticals develops anti-viral therapeutics based on Viral Decay Acceleration TM (VDA), a [...]
